$492.23
-3.53 (-0.71%)
LIN News8 articles
Linde Shares Decline Amid Energy Price Surge, Investor Focus on CFO Remarks
Linde plc shares dropped 1.6% to $501.45 Tuesday as surging energy prices triggered broad market declines. Attention now turns to the company's CFO speaking at a Raymond James conference on March 4.
Markets
Linde Shares Hold Gains Ahead of Investor Conferences
Linde shares gained 1.7% to close at $481.00 on Friday, approaching recent highs. Management will present at investor conferences starting Tuesday after the Presidents Day market holiday.
Markets
Linde Shares Rise Amid $36M Planned Sale, Upcoming Investor Conferences
Linde plc closed Friday at $481, a 1.7% increase, as markets prepared for a holiday closure. A filing disclosed plans to sell 75,607 shares worth approximately $36.1 million, while executives are scheduled for investor conferences on February 17-18.
Markets
Linde Shares Surge as Inflation Data Lifts Industrials
Linde shares gained 2.8% Friday, reaching a new intraday peak amid a broader market rebound fueled by easing inflation pressures. The industrial gases leader outperformed sector peers.
Markets
Linde Shares Gain Amid Diverging Analyst Views on Pricing Power
Linde shares rose 1.6% as BMO raised its price target to $507, while DZ Bank downgraded the stock to Hold, highlighting questions over industrial demand.
Analysis
Linde Shares Gain as Analysts Revise Targets Amid Strong Backlog Outlook
Linde shares rose 1.8% to $456.34 after analysts adjusted price targets, while the company projects robust 2026 earnings and maintains a record $10 billion project backlog.
Markets
Linde Shares Face Pressure After JPMorgan Downgrade, Focus Turns to Pricing Outlook
Linde stock fell 2.53% to $448.07 Friday after JPMorgan cut its rating to Neutral, citing valuation and flat sequential pricing. Investors await U.S. jobs data and company conferences this week.
Analysis
Linde Shares Slide on 2026 Guidance, JPMorgan Downgrade
Linde stock fell 2.5% after issuing 2026 EPS guidance below consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets.
Earnings